Neolitsea aciculata essential oil inhibits drug-resistant skin pathogen growth and Propionibacterium acnes-induced inflammatory effects of human monocyte leukemia

Natural Product Communications

Volumn 6, Issue 8, 2011, Pages 1193-1198

  Kim, Sang Suk ^a   Kim, Jung Eun ^c   Hyun, Chang Gu ^b   Lee, Nam Ho ^a  

^a Jeju National University   (South Korea)

^b Jeju Technopark   (South Korea)

^c NONE

Author keywords

Acne vulgaris; Essential oil; Inflammation; Neolitsea aciculata; Skin pathogen

Indexed keywords

1 DODECEN 3 YNE; 1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALPHA GURJUNENE; ALPHA MUUROLENE; ALPHA SELINENE; AMORPHENE; ANTIINFECTIVE AGENT; AROMADENDRENE; BETA ELEMENE; CALACORENE; CALAMENENE; CALARENE; CARYOPHYLLENE; CARYOPHYLLENE OXIDE; CINEOLE; COPAENE; DELTA CADINENE; ELEMOL; ESSENTIAL OIL; GAMMA CADINENE; HUMULENE; INTERLEUKIN 8; LINALOOL; NATURAL PRODUCT; NEOLITSEA ACICULATA EXTRACT; OCIMENE; SELINENE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALENCENE; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIPHENYL DERIVATIVE; PICRIC ACID; VEGETABLE OIL;

ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ISOLATION; HUMAN; HUMAN CELL; HYDRODISTILLATION; IC 50; MASS FRAGMENTOGRAPHY; MEDICINAL PLANT; MONOCYTIC LEUKEMIA; NEOLITSEA ACICULATA; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS EPIDERMIDIS; ANGIOSPERM; CHEMISTRY; DRUG EFFECT; MONOCYTE; TUMOR CELL LINE;

NEOLITSEA ACICULATA; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; HUMANS; LAURACEAE; MONOCYTES; OILS, VOLATILE; PICRATES; PLANT OILS; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 80054779100     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1100600837     Document Type: Article

References (38)

1. Dreno B, Poli F. (2003) Epidemiology of acne. Dermatology, 206, 7-10. (Pubitemid 36164660)
2. Tom WL, Barrio VR. (2008) New insights into adolescent acne. Current Opinion in Pediatrics, 20, 436-440.
3. Pearl A, Arroll B, Lello J, Birchall NM. (1998) The impact of acne: a study of adolescents' attitudes, perception and knowledge. The New Zealand Medical Journal, 111, 269-271. (Pubitemid 128472985)
4. Kilkenny M, Merlin K, Plunkett A, Marks R. (1998) The prevalence of common skin conditions in Australian school students: 3. Acne vulgaris. The British Journal of Dermatology, 139, 840-845.
5. Hassanzadeh P, Bahmani M, Mehrabani D. (2008) Bacterial resistance to antibiotics in acne vulgaris: An in vitro study. Indian Journal of Dermatology, 53, 122-124.
6. Smith KR, Thiboutot DM. (2008) Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? Journal of Lipid Research, 49, 271-281. (Pubitemid 351213612)
7. Holland DB, Bojar RA, Jeremy AH, Ingham E, Holland KT. (2008) Microbial colonization of an in vitro model of a tissue engineered human skin equivalent-a novel approach. FEMS Microbiology Letters, 279, 110-115. (Pubitemid 350308557)
8. Webster GF, Graber EM. (2008) Antibiotic treatment for acne vulgaris. Seminars in Cutaneous Medicine and Surgery, 27, 83-87.
9. Marcinkiewicz J. (2009) Taurine bromamine: a new therapeutic option in inflammatory skin diseases. Polskie Archiwum Medycyny Wewnetrznej, 119, 673-676.
10. Sagransky M, Yentzer BA, Feldman SR. (2009) Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opinion on Pharmacotherapy, 10, 2555-2562.
11. Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM. (2009) Changing the face of acne therapy. Cutis, 83, 4-15.
12. James KA, Burkhart CN, Morrell DS, (2009) Emerging drugs for acne. Expert Opinion on Emerging Drugs, 14, 649-659
13. Eady EA. (1998) Bacterial resistance in acne. Dermatology, 196, 59-66.
14. Wawruch M, Bozekova L, Krcmery S, Kriska M. (2002) Risks of antibiotic treatment. Bratislavské lekárske listy, 103, 270-275.
15. Kim SS, Kim JY, Lee NH, Hyun CG. (2008) Antibacterial and anti-inflammatory effects of Jeju medicinal plants against acne-inducing bacteria. Journal of General and Applied Microbiology, 54, 101-106. (Pubitemid 351850737)
16. Oh TH, Kim SS, Yoon WJ, Kim JY, Yang EJ, Lee NH, Hyun CG. (2009) Chemical composition and biological activities of Jeju Thymus quinquecostatus essential oils against Propionibacterium species inducing acne. Journal of General and Applied Microbiology, 55, 63-68.
17. Yoon WJ, Kim SS, Oh TH, Lee NH, Hyun CG. (2009) Torreya nucifera essential oil inhibits skin pathogen growth and lipopolysaccharide-induced inflammatory effects. International Journal of Pharmacology, 5, 37-43.
18. Yoon WJ, Kim SS, Oh TH, Lee NH, Hyun CG. (2009) Cryptomeria japonica essential oil inhibits the growth of drug-resistant skin pathogens and LPS-induced nitric oxide and pro-inflammatory cytokine production. Polish Journal of Microbiology, 58, 61-68.
19. Yoon WJ, Kim SS, Oh TH, Lee NH, Hyun CG. (2009) Abies koreana essential oil inhibits drug-resistant skin pathogen growth and LPS-induced inflammation effects of murine macrophage. Lipids, 44, 471-476.
20. Zesch A. (1988) Adverse reactions of externally applied drugs and inert substances. Dermatosen in Beruf und Umwelt. Occupation and Environment, 36, 128-133.
21. Piskin S, Uzunali E. (2007) A review of the use of adapalene for the treatment of acne vulgaris. Therapeutics and Clinical Risk Management, 3, 621-624. (Pubitemid 47496967)
22. Sloan B, Scheinfeld N. (2008) The use and safety of doxycycline hyclate and other second-generation tetracyclines. Expert Opinion on Drug Safety, 7, 571-577.
23. Del Rosso JQ, Kim G. (2009) Optimizing use of oral antibiotics in acne vulgaris. Dermatologic Clinics, 27, 33-42.
24. Yano K, Akihisa T, Tamura T, Matsumoto T. (1992) Four-4α- methylsterols and triterpene alcohols from Neolitsea aciculata. Phytochemistry, 31, 2093-2098.
25. Kim SS, Yoon WJ, Hyun CG, Lee NH. (2010) Down-regulation of tyrosinase, TRP-2 and MITF expression by Neolitsea aciculata extract in murine B16 F10 melanoma. International Journal of Pharmacology, 6, 290-295.
26. Yoon WJ, Moon JY, Kang JY, Kim GO, Lee NH, Hyun CG. (2010) Neolitsea sericea essential oil attenuates LPS-induced inflammation in RAW 264.7 macrophages by suppressing NF-κB and MAPK activation. Natural Product Communications, 5, 1311-1316.
27. Wu X, Vogler B, Jackes BR, Setzer WN. (2008) Terpenoids from Neolitsea dealbata, Natural Product Communications, 3, 129-132.
28. Padalia RC, Chanotiya CS, Thakuri BC, Mathela CS. (2007) Germacranolide rich essential oil from Neolitsea pallens. Natural Product Communications, 2, 591-593.
29. Aligiannis N, Kalpoutzakis E, Mitaku S, Chinou IB. (2001) Composition and antimicrobial activity of the essential oils of two Origanum species. Journal of Agricultural and Food Chemistry, 49, 4168-4170. (Pubitemid 32896404)
30. Yu J, Lei J, Yu H, Cai X, Zou G. (2004) Chemical composition and antimicrobial activity of the essential oil Scutellaria barbata, Phytochemistry, 65, 881-884. (Pubitemid 38471765)
31. Vowels BR, Yang S, Leyden JJ. (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infection and Immunity, 63, 3158-3165.
32. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, Urabe K, Furue M. (2002) Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. Journal of Dermatological Science, 29, 97-103.
33. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D. (2005) Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Medica, 71, 338-343. (Pubitemid 40676458)
34. Kim SS, Baik JS, Oh TH, Yoon WJ, Lee NH, Hyun CG. (2008) Biological activities of Korean Citrus obovoides and Citrus natsudaidai essential oils against acne-inducing bacteria. Bioscience Biotechnology and Biochemistry, 72, 2507-2513.
35. Leu SJ, Lin YP, Lin RD, Wen CL, Cheng KT, Hsu FL, Lee MH. (2006) Phenolic constituents of Malus doumeri var. formosana in the field of skin care. Biological & Pharmaceutical Bulletin, 29, 740-745.
36. Huang D, Ou B, Prior RL. (2005) The chemistry behind antioxidant capacity assays. Journal of Agricultural and Food Chemistry, 53, 1841-1856. (Pubitemid 40403051)
37. Zhu YZ, Huang SH, Tan BK, Sun J, Whiteman M, Zhu YC. (2004) Antioxidants in Chinese herbal medicines: a biochemical perspective. Natural Product Reports, 21, 478-489. (Pubitemid 39187836)
38. Sawai Y, Moon JH, Sakata K, Watanabe N. (2005) Effects of structure on radical-scavenging abilities and antioxidative activities of tea polyphenols: NMR analytical approach using 1,1-diphenyl-2-picrylhydrazyl radicals. Journal of Agricultural and Food Chemistry, 53, 3598-3604. (Pubitemid 40758201)